Impacts of FDA Approval and Medicare Restriction on Antiamyloid Therapies for Alzheimer’s Disease: Patient Outcomes, Healthcare Costs, and Drug Development
Faculty Publications
Part of the Pharmacy and Pharmaceutical Sciences Commons
Part of the Pharmacy and Pharmaceutical Sciences Commons